20 millions. This is the number of French people affected by presbyopia, as reported by the Adolphe de Rothschild Foundation Hospital. This is a gradual reduction in the eye’s accommodating power, which is called focusing. Result: near vision is disturbed.
To support presbyopia, which usually appears around the age of 40 to 45, wearing glasses or contact lenses is necessary. It is also possible to use the refractive surgery.
What if a simple eye drop might correct presbyopia? If this idea seems utopian, it is nevertheless a reality: an American company has developed eye drops to treat presbyopia. It is already available by prescription in pharmacies in the United States.
This revolutionary eye drops called Vuity was designed by the company Allergan, which belongs to the AbbVie group. It contains pilocarpine, a substance already used in the treatment of glaucoma, as well as a technology created by Allergan, called pHast. This eye drops “uses the eye’s own ability to reduce the size of the pupil, thus improving near and intermediate vision while maintaining distance vision”, can we read in a press release.
Approved by the Food and Drug Administration (FDA) last October, this product was available in American pharmacies. A green light given at the end of clinical trials conducted on 750 participants aged 40 to 55 and (…)
